RBC Capital sets a price target of $13 for ARDT, indicating a potential increase of approximately 41.77%. A class action lawsuit alleges securities fraud against Ardent Health, potentially impacting ...
Heritage Insurance Holdings, Inc. (NYSE:HRTG) rep...
Daniil Gataulin from Chardan Capital set a price ...
FuelCell Energy reported an EPS of -$0.49, surpassing the estimated EPS of -$0.68, yet its revenue of $30.5 million missed the forecast by a significant margin. The company has shown a 61% year-over-
Bank of America Securities reaffirms its "Buy" rating for Cisco Systems Inc. (NASDAQ:CSCO), signaling confidence in the company's future performance. The average brokerage recommendation (ABR) of 1.7
Olema Pharmaceuticals Inc. (NASDAQ:OLMA) is focused on developing targeted therapies for women's cancers, with collaborations with Pfizer Inc. and Novartis AG. Despite a recent price target of $38 by
Director Robert D. Fisher's purchase of 213 shares indicates confidence in NASDAQ:CHCO's future. Citigroup Inc. reduces its stake in CHCO by 23.2%, contrasting with Fisher's optimistic view. Royal Ba
Earnings per share (EPS) of $0.22 fell short of the estimated $0.38, while revenue of $428.8 million surpassed expectations. ACCO's strategic acquisition of EPOS aims to enhance its technology periph
Sergey Glinyanov from Loop Capital Markets sets a price target of $57 for ITRN, indicating a potential increase of 17.04%. Ituran reported record financial results in 2025, with a 13% increase in Q4
